ClinicalTrials.Veeva

Menu

Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients

Zhejiang University logo

Zhejiang University

Status

Enrolling

Conditions

Coronary Artery Disease

Treatments

Diagnostic Test: Routine Clinical Follow-up
Diagnostic Test: Routine Angiography Follow-up

Study type

Interventional

Funder types

Other

Identifiers

NCT05923489
2023-0332

Details and patient eligibility

About

Comparison of clinical outcomes between routine angiography follow-up and routine clinical follow-up after percutaneous coronary intervention in high-risk patients.

Enrollment

2,618 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years.
  • Successful PCI with at least two of the following high-risk factors:

A. Left main lesion; B. Bifurcation lesion (true bifurcation); C. Ostial lesion of main vessels (left anterior descending, left circumflex artery, right coronary artery); D. Chronic total occlusion; E. Multivessel revascularization (≥ 2 vessels); F. In-stent restenosis; G. Diffuse long lesion (lesion length ≥ 30 mm or stent length ≥ 38 mm); H. Severe calcified lesion (Significant severe calcification on angiography); I. Bypass graft lesion; J. Diabetes mellitus; K. Chronic kidney disease (defined as an estimated glomerular filtration rate of <30 ml per minute per 1.73 m2 of body-surface area or the receipt of dialysis); L. Myocardial infarction;

  • He/she or his/her legally authorized representative provides written informed

Exclusion criteria

  • Revascularization with bare metal stents and/or balloon angioplasty with non-drug-coated balloons.
  • Pregnant and/or lactating women.
  • Life expectancy of less than 2 years.
  • Repeat interventional therapy is planned.
  • Subject was unable to provide written informed consent.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

2,618 participants in 2 patient groups

Routine Angiography Follow-up (RAF) group
Experimental group
Description:
Patients in the RAF group will have routine angiography follow-up at 12 months after revascularization.
Treatment:
Diagnostic Test: Routine Angiography Follow-up
Routine Clinical Follow-up (RCF) group
Active Comparator group
Description:
Patients in the RCF group will have routine clinical follow-up at 12 months after revascularization, and the physician will decide whether further invasive testing is needed.
Treatment:
Diagnostic Test: Routine Clinical Follow-up

Trial contacts and locations

1

Loading...

Central trial contact

Jun Jiang, MD, PhD; Jinlong Zhang, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems